Matches in SemOpenAlex for { <https://semopenalex.org/work/W2555363460> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2555363460 abstract "Background: The two replicate, 52-week, Phase III INPULSIS ® trials investigated the efficacy and safety of nintedanib 150 mg twice daily (bid) in patients with idiopathic pulmonary fibrosis. Inclusion criteria included a diffusing capacity of the lung for carbon monoxide (DLco) of 30–79% predicted. In both trials, nintedanib significantly reduced the annual rate of decline in forced vital capacity (FVC), the primary endpoint, versus placebo. Aim: To assess the potential impact of DLco % predicted on the treatment effect of nintedanib. Methods: Post-hoc analyses of patients with baseline DLco >40% versus ≤40% predicted were conducted using pooled data from both INPULSIS ® trials. Results: A total of 709 patients (nintedanib 428; placebo 281) had DLco >40% predicted and 351 patients (nintedanib 210; placebo 141) had DLco ≤40% predicted. For patients with baseline DLco >40% predicted, mean age was 66.4 years, 80.8% were male and mean FVC was 83.3% predicted. For patients with baseline DLco ≤40% predicted, mean age was 67.4 years, 76.4% were male and mean FVC was 72.1% predicted. In patients with baseline DLco >40% predicted, the nintedanib versus placebo difference in adjusted annual rate of decline in FVC was 103.1 mL/year (95% CI: 63.6, 142.6); in patients with baseline DLco ≤40% predicted, it was 124.3 mL/year (95% CI: (56.2, 192.4). There was no significant treatment-by-time-by-subgroup interaction (p=0.1468), indicating that the treatment effect of nintedanib was not different between the subgroups. Conclusion: In a subgroup analysis of pooled data from the INPULSIS ® trials, nintedanib slowed disease progression irrespective of the level of gas exchange impairment at baseline." @default.
- W2555363460 created "2016-11-30" @default.
- W2555363460 creator A5002422862 @default.
- W2555363460 creator A5010115182 @default.
- W2555363460 creator A5019441565 @default.
- W2555363460 creator A5026940499 @default.
- W2555363460 creator A5050978023 @default.
- W2555363460 creator A5058325633 @default.
- W2555363460 creator A5060024548 @default.
- W2555363460 creator A5091576695 @default.
- W2555363460 date "2016-09-01" @default.
- W2555363460 modified "2023-09-23" @default.
- W2555363460 title "No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib" @default.
- W2555363460 doi "https://doi.org/10.1183/13993003.congress-2016.oa4959" @default.
- W2555363460 hasPublicationYear "2016" @default.
- W2555363460 type Work @default.
- W2555363460 sameAs 2555363460 @default.
- W2555363460 citedByCount "0" @default.
- W2555363460 crossrefType "proceedings-article" @default.
- W2555363460 hasAuthorship W2555363460A5002422862 @default.
- W2555363460 hasAuthorship W2555363460A5010115182 @default.
- W2555363460 hasAuthorship W2555363460A5019441565 @default.
- W2555363460 hasAuthorship W2555363460A5026940499 @default.
- W2555363460 hasAuthorship W2555363460A5050978023 @default.
- W2555363460 hasAuthorship W2555363460A5058325633 @default.
- W2555363460 hasAuthorship W2555363460A5060024548 @default.
- W2555363460 hasAuthorship W2555363460A5091576695 @default.
- W2555363460 hasConcept C126322002 @default.
- W2555363460 hasConcept C142724271 @default.
- W2555363460 hasConcept C16020263 @default.
- W2555363460 hasConcept C165637977 @default.
- W2555363460 hasConcept C204787440 @default.
- W2555363460 hasConcept C27081682 @default.
- W2555363460 hasConcept C2776780178 @default.
- W2555363460 hasConcept C2777714996 @default.
- W2555363460 hasConcept C2778341716 @default.
- W2555363460 hasConcept C2780171596 @default.
- W2555363460 hasConcept C3018587741 @default.
- W2555363460 hasConcept C55520419 @default.
- W2555363460 hasConcept C71924100 @default.
- W2555363460 hasConceptScore W2555363460C126322002 @default.
- W2555363460 hasConceptScore W2555363460C142724271 @default.
- W2555363460 hasConceptScore W2555363460C16020263 @default.
- W2555363460 hasConceptScore W2555363460C165637977 @default.
- W2555363460 hasConceptScore W2555363460C204787440 @default.
- W2555363460 hasConceptScore W2555363460C27081682 @default.
- W2555363460 hasConceptScore W2555363460C2776780178 @default.
- W2555363460 hasConceptScore W2555363460C2777714996 @default.
- W2555363460 hasConceptScore W2555363460C2778341716 @default.
- W2555363460 hasConceptScore W2555363460C2780171596 @default.
- W2555363460 hasConceptScore W2555363460C3018587741 @default.
- W2555363460 hasConceptScore W2555363460C55520419 @default.
- W2555363460 hasConceptScore W2555363460C71924100 @default.
- W2555363460 hasLocation W25553634601 @default.
- W2555363460 hasOpenAccess W2555363460 @default.
- W2555363460 hasPrimaryLocation W25553634601 @default.
- W2555363460 hasRelatedWork W1896745119 @default.
- W2555363460 hasRelatedWork W2038320582 @default.
- W2555363460 hasRelatedWork W2056570112 @default.
- W2555363460 hasRelatedWork W2059459008 @default.
- W2555363460 hasRelatedWork W2098545954 @default.
- W2555363460 hasRelatedWork W2341412218 @default.
- W2555363460 hasRelatedWork W2524005801 @default.
- W2555363460 hasRelatedWork W2557106527 @default.
- W2555363460 hasRelatedWork W2561981946 @default.
- W2555363460 hasRelatedWork W2569832671 @default.
- W2555363460 hasRelatedWork W2777232717 @default.
- W2555363460 hasRelatedWork W2811389906 @default.
- W2555363460 hasRelatedWork W2901235303 @default.
- W2555363460 hasRelatedWork W2980575734 @default.
- W2555363460 hasRelatedWork W2991162217 @default.
- W2555363460 hasRelatedWork W3082109398 @default.
- W2555363460 hasRelatedWork W3096317577 @default.
- W2555363460 hasRelatedWork W3097038268 @default.
- W2555363460 hasRelatedWork W3107410078 @default.
- W2555363460 hasRelatedWork W2529939697 @default.
- W2555363460 isParatext "false" @default.
- W2555363460 isRetracted "false" @default.
- W2555363460 magId "2555363460" @default.
- W2555363460 workType "article" @default.